Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 50, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 January 2026 - 16:00

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 50, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/exelon

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters